News

Few newly diagnosed diabetics trained in self-management


 

FROM MORBIDITY AND MORTALITY WEEKLY REPORT

References

Among insured patients with diabetes, only 6.8% participated in self-management education and training within 1 year of their diagnosis, the Centers for Disease Control and Prevention reported.

There was some variation in the rate of diabetes self-management education and training (DSMT) across various subgroups, but none reached a participation rate higher than 14.2% in a study analyzing 2009-2012 data for 95,555 persons in the Marketscan Commercial Claims and Encounters database (MMWR 2014;63:1045-9).

That 14.2% participation rate was achieved among patients treated with insulin (with or without antiglycemic medication), which was somewhat offset by the small percentage who were using insulin (6.8%). Those taking oral antiglycemics – by far the largest treatment group – had a 6.7% DSMT participation rate and those not taking antiglycemics had a rate of only 5.1%, the CDC reported.

The older of the two age groups in the study, 45- to 69-year-olds, was slightly more likely to participate in DSMT (7.2%) than were those aged 18-44 years (5.9), while men and women were equally likely to participate (6.8%), the Marketscan data showed.

“The finding of low rates of participation in DSMT among privately insured adults with newly diagnosed diabetes underscores the need to identify specific barriers to access and participation in DSMT along with strategies to overcome these barriers,” the CDC investigators wrote.

rfranki@frontlinemedcom.com

Recommended Reading

Obesity, diabetes spur on group A strep infections
MDedge Endocrinology
Digital resource provides tips on diabetes management, treatment
MDedge Endocrinology
Internet program spurs 5.5-kg weight loss
MDedge Endocrinology
Functional MRI shows diabetes-induced cognitive deficits in elderly
MDedge Endocrinology
Presurgical BMI doesn’t predict diabetes remission
MDedge Endocrinology
CABG beats PCI for revascularization of diabetics
MDedge Endocrinology
On-target glycemic control does not lessen excess mortality
MDedge Endocrinology
ZS-9 promotes normokalemia in patients with diabetes and CKD
MDedge Endocrinology
Simple risk score predicts dementia risk in type 2 diabetes
MDedge Endocrinology
Liraglutide lowers HbA1c in diabetic CKD patients
MDedge Endocrinology